PTAB challenges

Proceedings overview

One AIA trial proceeding has been filed against US Patent 11192568. This proceeding, IPR2025-01100, was denied institution on a discretionary basis. This means the patent's claims have not been challenged on the merits at the PTAB, offering a defendant limited direct defensive value from this particular proceeding, as the claims remain untested by an IPR.

IPR2025-01100 — Evenflo Company, Inc. et al. v. Jon Hee Lee et al. (Patent Owner: Baby Jogger II LLC)

• Type: Inter Partes Review
• Filed: 2025-06-06
• Status: Discretionary Denial — The PTAB declined to institute the IPR on discretionary grounds, meaning the merits of the petition's patentability challenges were not fully considered.
• Judge panel: Administrative Patent Judges Jennifer H. Meyer, Rama G. Elluru, and Brian C. Lynch.
• Petition grounds: The petition challenged claims 1-20 of US Patent 11,192,568 B2 based on obviousness under 35 U.S.C. § 103 and anticipation under 35 U.S.C. § 102, citing various prior art references including US 2010/0140902 (Lee) and US 8,955,869 (Lee).
• Institution decision: Denied — 2026-01-08. The PTAB denied institution based on discretionary grounds, specifically referencing the Fintiv factors. The Board found that a co-pending district court litigation weighed against institution, citing factors such as the advanced stage of the parallel district court litigation and the overlap in issues and evidence between the IPR and the district court case.
• Final Written Decision: Not issued, as institution was denied.
• Settlement / termination: Not applicable; institution was denied.
• Appeal: No appeal to the Federal Circuit was made, as institution was denied.
• Defensive value: This proceeding indicates that Evenflo Company, Inc. attempted to challenge the patent via IPR but was unsuccessful due to the PTAB's discretionary denial, likely influenced by parallel district court litigation. The patent claims themselves were not evaluated on the merits. Thus, an IPR-based defense on the same grounds might be difficult for Evenflo or its privies due to potential Fintiv issues if there is ongoing parallel litigation, but the underlying patentability of the claims remains untested by this IPR.

Strategic summary

Currently, claims 1-20 of US11192568 are considered SUSTAINED by virtue of never having been subjected to a full merits review at the PTAB. The single IPR filed, IPR2025-01100 by Evenflo Company, Inc., was denied institution on discretionary grounds, not based on a finding of patentability of the challenged claims. This means all claims of the patent have survived PTAB scrutiny procedurally, but not substantively.

The estoppel landscape related to IPR2025-01100 is somewhat complex. While a statutory estoppel under 35 U.S.C. § 315(e)(1) and (2) typically arises from a Final Written Decision, a discretionary denial under Fintiv can still lead to judicial estoppel in subsequent district court proceedings if the petitioner raised substantially the same arguments. For Evenflo Company, Inc. and its privies, the specific grounds raised in their petition may face challenges in future litigation, particularly in the district court where the Fintiv denial was based. However, for other defendants, the prior art grounds (obviousness under § 103 and anticipation under § 102 based on Lee and other references) are theoretically still available, provided they are not in privity with Evenflo and do not face similar Fintiv-type arguments (e.g., being in a very advanced stage of parallel litigation).

There is a clear pattern signal here: Evenflo Company, Inc. initiated this IPR, indicating that they perceive a threat from the patent. The discretionary denial suggests that the patent owner, Baby Jogger II LLC, successfully argued for the denial, likely leveraging the presence and stage of co-pending district court litigation. This signifies an active enforcement strategy by the patent owner.

Recommended next steps

• For any defendant facing assertion of US11192568, it is important to review the PTAB's Institution Decision for IPR2025-01100 (Paper 15 in IPR2025-01100) to understand the precise reasoning behind the discretionary denial and the specific Fintiv factors cited. This decision can be found on the USPTO PTAB Decisions portal.
• A comprehensive prior art search beyond the references cited in IPR2025-01100 would be prudent if a new IPR challenge is being considered, especially since the claims have not been substantively vetted by the PTAB.
• Evaluate the status of any co-pending district court litigation mentioned in the IPR decision. The existence and stage of such litigation were key to the discretionary denial, and this context is crucial for understanding the patent owner's enforcement strategy and the potential for future PTAB challenges.
• Given the "Discretionary Denial" status, the one-year trial deadline from institution does not apply, as the trial was not instituted. All claims of the patent are currently enforceable.